Evidence map›Paper›PMID 32402369›Full record

ArticleActas dermo-sifiliograficas2020

Chilblain and Acral Purpuric Lesions in Spain during Covid Confinement: Retrospective Analysis of 12 Cases.

J Romaní, E Baselga, O Mitjà, N Riera-Martí, P Garbayo, A Vicente, M Casals, V Fumadó, C Fortuny, S Calzado

Abstract readCase Reports
In one paragraph

Article in Actas dermo-sifiliograficas, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pediatric COVID toes and fingers.Clinics in dermatology
    Pooled it
  4. Article
  5. Article
  6. Review
  7. Skin manifestations of COVID-19 in children: Part 1.Clinical and experimental dermatology · 2021
    Review
  8. Article
  9. Article
  10. Vesicular (varicella-like) eruptions.Enfermedades infecciosas y microbiologia clinica (English ed.) · 2021
    Article
  11. Article
  12. [Spanish Dermatology in the COVID-19 Era].Actas dermo-sifiliograficas · 2020
    Article
  13. Article
  14. SARS-CoV-2, skin lesions and the need of a multidisciplinary approach.Journal of the European Academy of Dermatology and Venereology : JEADV · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

J RomaníDepartamento de Dermatología, Consorci Sanitari Parc Taulí, Sabadell, Barcelona, España. Electronic address: jromani@tauli.cat.
E BaselgaDepartamento de Dermatología, Hospital Sant Joan de Deu, Barcelona, España.
O MitjàEnfermedades Infecciosas y Salud Global, Hospital Germans Trias i Pujol, Badalona, Barcelona, España.
N Riera-MartíEnfermedades Infecciosas y Salud Global, Hospital Germans Trias i Pujol, Badalona, Barcelona, España.
P GarbayoDepartamento de Dermatología, Consorci Sanitari Parc Taulí, Sabadell, Barcelona, España.
A VicenteDepartamento de Dermatología, Hospital Sant Joan de Deu, Barcelona, España.
M CasalsDepartamento de Dermatología, Consorci Sanitari Parc Taulí, Sabadell, Barcelona, España.
V FumadóDepartamento de Enfermedades Infecciosas, Hospital Sant Joan de Deu, Barcelona, España.
C FortunyDepartamento de Enfermedades Infecciosas, Hospital Sant Joan de Deu, Barcelona, España.
S CalzadoDepartamento de Enfermedades Infecciosas, Consorci Sanitari Parc Taulí, Sabadell, Barcelona, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChilblainsCOVID-19HumansRetrospective StudiesSARS-CoV-2Spain

Identifiers

PMID32402369
PMCPMC7174170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.